Sun Jennifer K, Radwan Salma H, Soliman Ahmed Z, Lammer Jan, Lin Michael M, Prager Sonja G, Silva Paolo S, Aiello Lloyd Bryce, Aiello Lloyd Paul
Beetham Eye Institute, Joslin Diabetes Center, Boston, MA Department of Ophthalmology, Harvard Medical School, Boston, MA
Department of Ophthalmology, University of Minnesota, Minneapolis, MN Department of Ophthalmology, Cairo University, Cairo, Egypt.
Diabetes. 2015 Jul;64(7):2560-70. doi: 10.2337/db14-0782. Epub 2015 Jan 29.
Despite treatment advances, diabetic eye disease remains a leading cause of visual acuity (VA) loss worldwide. No methods to prospectively determine which patients will gain or lose vision exist, limiting individualized risk assessment and management. We investigated whether noninvasive, readily obtainable spectral domain optical coherence tomography parameters were correlated with VA in eyes with current or resolved center-involved diabetic macular edema (DME). Images were evaluated for disorganization of the retinal inner layers (DRIL), cysts, epiretinal membranes, microaneurysms, subretinal fluid, and outer layer disruption/reflectivity. DRIL affecting ≥50% of the 1-mm central retinal zone was associated with worse VA in all eyes, eyes with current edema, and eyes with resolved edema. Furthermore, early 4-month change in DRIL extent predicted VA change from baseline to 1 year. These data suggest that DRIL is a robust predictor of VA in eyes with present or previous DME and more highly correlated with VA than other widely used measures, such as retinal thickness. If further studies confirm DRIL as a predictive biomarker of future VA, physicians would gain a new tool of substantial clinical and investigative importance that could significantly change the approach to ophthalmic counseling and therapeutic management in patients with diabetes.
尽管治疗取得了进展,但糖尿病眼病仍是全球视力丧失的主要原因。目前尚无前瞻性确定哪些患者视力会改善或下降的方法,这限制了个体化风险评估和管理。我们研究了在患有当前或已消退的累及中心的糖尿病性黄斑水肿(DME)的眼中,无创且易于获得的光谱域光学相干断层扫描参数是否与视力相关。对图像进行评估,观察视网膜内层紊乱(DRIL)、囊肿、视网膜前膜、微动脉瘤、视网膜下液以及外层破坏/反射率情况。累及1毫米中央视网膜区域≥50%的DRIL与所有眼睛、有当前水肿的眼睛以及水肿已消退的眼睛的较差视力相关。此外,DRIL范围在4个月时的早期变化可预测从基线到1年的视力变化。这些数据表明,DRIL是患有当前或既往DME的眼睛视力的有力预测指标,并且与视力的相关性比其他广泛使用的指标(如视网膜厚度)更高。如果进一步的研究证实DRIL是未来视力的预测生物标志物,医生将获得一个具有重大临床和研究意义的新工具,这可能会显著改变糖尿病患者眼科咨询和治疗管理的方法。